RxDoctor Payments Data

Eric Russell, MD

Dermatology · Conway, ARNPI 1033198510

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.0% of the total across 246 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Johnson & Johnson at 24.5% of the total. Reporting peaked in 2023 at $827 and has fallen 55.5% since, to $368 in 2025.

$4,120in general payments, 2019–2025

Across 246 payments — averaging $16.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • AbbVie$709
  • Sun Pharmaceutical Industries Inc.$632
  • UCB, Inc.$390
  • Pfizer$370
  • Lilly USA, LLC$369
  • plus $641 from 10 others

What the payments were for

  • Food & beverage$3,91295%
  • Education$2085%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,120 in reported general payments places this provider in the 55th percentile of 75 dermatology providers in Arkansas.

See all dermatology providers in Arkansas

Medicare billing

Part B allowed, 2024
$265,023
Medicare patients
1,068
Services billed
4,055

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluorouracil66$5,465
Doxycycline Hyclate103$3,319
Triamcinolone Acetonide131$2,139
Ketoconazole82$2,029
Mycophenolate Mofetil24$1,907
Clobetasol Propionate45$1,876
Betamethasone Dipropionate36$1,150
Metronidazole19$1,104
MethotrexateMethotrexate Sodium23$819
Clindamycin Phosphate20$674
Dapsone12$639
ValacyclovirValacyclovir Hcl25$636
Hydroxychloroquine Sulfate16$536
Nystatin21$378
CiclopiroxCiclopirox Olamine16$361

Paid to pharmacies, not to this prescriber.

Other dermatology in Conway

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →